Awards & QUALIFICATIONS
- The Founder's Cup, Oxford Ophthalmological Congress, 2018
- Fellow of the Royal College of Ophthalmologists, 2016
- MRC/Fight for Sight Clinical Research Training Fellowship, 2015
- Crombie Medal, Royal College of Ophthalmologists 2011
- BM BCh with Distinction, University of Oxford 2010
- MA (First Class), University of Cambridge 2007
- Swann Prize for Biology, Gonville & Caius College, Cambridge 2007
- Ian Gordon-Smith Prize for Medicine, Gonville & Caius College, Cambridge 2005
MA (Cantab) BM BCh DPhil FRCOphth
Honorary Research Associate
- Specialist Registrar and Locum Consultant (Accident & Emergency), Moorfields Eye Hospital, London
Harry's background is in Clinical Ophthalmology as a Specialist Registrar within the North London/Moorfields Eye Hospital training rotation.
Harry's research focusses on developing a new gene-therapy based treatment for dominant retinitis pigmentosa (RP) caused by defects in the rhodopsin gene. These mutations account for around a quarter of all cases of dominant RP and are one of the most common genetic cause of sight loss in the UK.
Corazza P. et al, (2020), Ophthalmologica
Orlans HO. et al, (2020), Exp Eye Res, 190
Orlans HO. and MacLaren RE., (2019), Eye (Lond)
Filtration of short-wavelength light provides therapeutic benefit in Retinitis Pigmentosa caused by a common rhodopsin mutation.
(2019), Investigative ophthalmology and Visual Science
Mirtron gene therapy for the treatment of rhodopsin-related dominant retinitis pigmentosa
Orlans HO. et al, (2019), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 60